应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VERA Vera Therapeutics, Inc.
未开盘 07-15 16:00:00 EDT
23.20
-0.58
-2.44%
盘后
23.45
+0.25
+1.08%
19:20 EDT
最高
23.91
最低
22.95
成交量
118.05万
今开
23.83
昨收
23.78
日振幅
4.04%
总市值
14.80亿
流通市值
10.88亿
总股本
6,377万
成交额
2,738万
换手率
2.52%
流通股本
4,689万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Scotiabank:维持Vera Therapeutics(VERA.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由55.00美元调整至65.00美元。
金融界 · 06-02
Scotiabank:维持Vera Therapeutics(VERA.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由55.00美元调整至65.00美元。
Vera therapeutics股价开盘大涨69%,创2021年以来最大涨幅
每日经济新闻 · 06-02
Vera therapeutics股价开盘大涨69%,创2021年以来最大涨幅
戴尔科技计划支持英伟达VERA CPU并推出AI新方案
DoNews · 05-19
戴尔科技计划支持英伟达VERA CPU并推出AI新方案
戴尔科技:计划支持英伟达VERA CPU;计划用新款戴尔PowerEdge XE服务器支持英伟达VERA RUBIN平台。
金融界 · 05-19
戴尔科技:计划支持英伟达VERA CPU;计划用新款戴尔PowerEdge XE服务器支持英伟达VERA RUBIN平台。
Vera Therapeutics, Inc.盘中异动 早盘大幅拉升5.90%报22.99美元
市场透视 · 05-12
Vera Therapeutics, Inc.盘中异动 早盘大幅拉升5.90%报22.99美元
异动解读 | Vera Therapeutics盘中大涨5.17%,分析师维持买入评级目标价75美元
异动解读 · 05-09
异动解读 | Vera Therapeutics盘中大涨5.17%,分析师维持买入评级目标价75美元
Vera Therapeutics, Inc.盘中异动 早盘急速下跌5.39%
市场透视 · 05-08
Vera Therapeutics, Inc.盘中异动 早盘急速下跌5.39%
坎托菲茨杰拉德公司:维持Vera Therapeutics评级
证券之星 · 05-07
坎托菲茨杰拉德公司:维持Vera Therapeutics评级
Vera Therapeutics, Inc.盘中异动 大幅跳水5.05%报24.24美元
市场透视 · 05-06
Vera Therapeutics, Inc.盘中异动 大幅跳水5.05%报24.24美元
HC Wainwright & Co.:假定Vera Therapeutics(VERA.US)买入评级, 目标价75.00美元。
金融界 · 05-05
HC Wainwright & Co.:假定Vera Therapeutics(VERA.US)买入评级, 目标价75.00美元。
Vera Therapeutics, Inc.盘中异动 股价大涨5.03%报24.95美元
市场透视 · 05-02
Vera Therapeutics, Inc.盘中异动 股价大涨5.03%报24.95美元
Vera Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%报22.91美元
市场透视 · 04-11
Vera Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%报22.91美元
Vera Therapeutics, Inc.盘中异动 下午盘股价大跌5.10%报27.35美元
市场透视 · 03-10
Vera Therapeutics, Inc.盘中异动 下午盘股价大跌5.10%报27.35美元
Vera Therapeutics, Inc.盘中异动 股价大涨5.28%报30.11美元
市场透视 · 03-05
Vera Therapeutics, Inc.盘中异动 股价大涨5.28%报30.11美元
Vera Therapeutics, Inc.盘中异动 股价大跌5.08%
市场透视 · 03-03
Vera Therapeutics, Inc.盘中异动 股价大跌5.08%
Vera Therapeutics, Inc.盘中异动 早盘股价大涨5.08%报29.18美元
市场透视 · 02-27
Vera Therapeutics, Inc.盘中异动 早盘股价大涨5.08%报29.18美元
Vera Therapeutics, Inc.盘中异动 快速拉升5.06%报28.47美元
市场透视 · 02-26
Vera Therapeutics, Inc.盘中异动 快速拉升5.06%报28.47美元
Vera Therapeutics 2024 财年 GAAP 每股收益 $(2.75) 超过 $(2.83) 预期
财报速递 · 02-26
Vera Therapeutics 2024 财年 GAAP 每股收益 $(2.75) 超过 $(2.83) 预期
Vera Therapeutics, Inc.盘中异动 急速拉升6.34%
市场透视 · 02-18
Vera Therapeutics, Inc.盘中异动 急速拉升6.34%
Vera Therapeutics, Inc.盘中异动 股价大跌5.03%
市场透视 · 02-14
Vera Therapeutics, Inc.盘中异动 股价大跌5.03%
加载更多
公司概况
公司名称:
Vera Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Vera Therapeutics, Inc.最初于2016年5月在特拉华州注册成立,名称为CDF Therapeutics,Inc.,并于2020年4月更名为Vera Therapeutics, Inc.。该公司是一家处于临床后期阶段的生物技术公司,专注于为患有严重免疫疾病的患者开发和商业化转化疗法。该公司的主要候选产品atacicept是一种自我给药的融合蛋白,可阻断B淋巴细胞刺激物和增殖诱导配体,具有治疗IgA肾病的同类最佳潜力。
发行价格:
--
{"stockData":{"symbol":"VERA","market":"US","secType":"STK","nameCN":"Vera Therapeutics, Inc.","latestPrice":23.2,"timestamp":1752609600000,"preClose":23.78,"halted":0,"volume":1180468,"hourTrading":{"tag":"盘后","latestPrice":23.45,"preClose":23.2,"latestTime":"19:20 EDT","volume":31626,"amount":733949.1,"timestamp":1752621628472},"delay":0,"floatShares":46894586,"shares":63774158,"eps":-2.999217,"marketStatus":"未开盘","change":-0.58,"latestTime":"07-15 16:00:00 EDT","open":23.83,"high":23.91,"low":22.95,"amount":27382963.236068003,"amplitude":0.04037,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.999217,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752652800000},"marketStatusCode":0,"adr":0,"listingDate":1620964800000,"exchange":"NASDAQ","adjPreClose":23.78,"preHourTrading":{"tag":"盘前","latestPrice":23.82,"preClose":23.78,"latestTime":"09:28 EDT","volume":4578,"amount":108829.923594,"timestamp":1752586080059},"postHourTrading":{"tag":"盘后","latestPrice":23.45,"preClose":23.2,"latestTime":"19:20 EDT","volume":31626,"amount":733949.1,"timestamp":1752621628472},"volumeRatio":1.465858,"impliedVol":0.4523,"impliedVolPercentile":0.08},"requestUrl":"/m/hq/s/VERA","defaultTab":"news","newsList":[{"id":"2540679727","title":"Scotiabank:维持Vera Therapeutics(VERA.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由55.00美元调整至65.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2540679727","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540679727?lang=zh_cn&edition=full","pubTime":"2025-06-03 01:42","pubTimestamp":1748886174,"startTime":"0","endTime":"0","summary":"Scotiabank:维持Vera Therapeutics(VERA.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由55.00美元调整至65.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/03014250813040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VERA","LENZ"],"gpt_icon":0},{"id":"2540779526","title":"Vera therapeutics股价开盘大涨69%,创2021年以来最大涨幅","url":"https://stock-news.laohu8.com/highlight/detail?id=2540779526","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540779526?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:44","pubTimestamp":1748871844,"startTime":"0","endTime":"0","summary":"每经AI快讯,6月2日,Veratherapeutics股价开盘大涨69%,创2021年以来最大涨幅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202506023419960979.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202506023419960979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","VERA","BK4539","BK4585","BK4139"],"gpt_icon":0},{"id":"2536863631","title":"戴尔科技计划支持英伟达VERA CPU并推出AI新方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2536863631","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536863631?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:49","pubTimestamp":1747673342,"startTime":"0","endTime":"0","summary":"5月20日,戴尔科技宣布计划支持英伟达VERA CPU,并在新款PowerEdge XE服务器中引入英伟达VERA RUBIN平台。双方将合作推出下一代企业级人工智能解决方案,旨在提升企业在AI领域的计算能力与效率。此举有助于推动AI技术在各行业的应用与发展。免责声明:本文内容由开放的智能模型自动生成,仅供参考。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052000502294fbb5b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052000502294fbb5b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERA","LU1323610961.USD","LU2357125470.USD","LU0256863902.USD","LU1712237335.SGD","LU1861215975.USD","NVIW.SI","LU0203202063.USD","IE00BJTD4N35.SGD","LU0124676726.USD","3NVD.UK","DELL","LU2471134952.CNY","NVD2.UK","NVDA","LU2023250330.USD","LU0979878070.USD","IE0004086264.USD","LU1914381329.SGD","NVDY","LU0082616367.USD","LU0823421333.USD","LU0444971666.USD","LU2106854487.HKD","NVDD","NVDU","BK4503","2NVD.UK","LU1037948541.HKD","LU1989772923.USD","LU2077746001.SGD","LU1868836757.USD","LU1127390331.HKD","LU2417539215.USD","LU2552382215.SGD","NVD3.UK","LU2552382058.USD","NVDS.UK","LU0889565833.HKD","LU1366192091.USD","LU0266013472.USD","LU1267930730.SGD","NVDS","LU2191332357.HKD","NVD","SNVD.UK","BK4532","SG9999015358.SGD"],"gpt_icon":0},{"id":"2536639913","title":"戴尔科技:计划支持英伟达VERA CPU;计划用新款戴尔PowerEdge XE服务器支持英伟达VERA RUBIN平台。","url":"https://stock-news.laohu8.com/highlight/detail?id=2536639913","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536639913?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:35","pubTimestamp":1747672517,"startTime":"0","endTime":"0","summary":"戴尔科技:计划支持英伟达VERA CPU;计划用新款戴尔PowerEdge XE服务器支持英伟达VERA RUBIN平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052000390094fbb3cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052000390094fbb3cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1791710582.SGD","LU0234570918.USD","LU0267386448.USD","LU2236285917.USD","LU2023250504.SGD","LU0345768740.USD","NVD2.UK","BK4515","BK4548","LU0353189763.USD","LU0708995401.HKD","LU0061474960.USD","LU0175139822.USD","LU2452424414.USD","LU1323610961.USD","LU0215105999.USD","NVDS","LU0072462426.USD","LU0882574139.USD","LU2750360997.AUD","NVIW.SI","LU2458330243.SGD","HK0000320264.USD","LU0256863902.USD","NVDD","DELL","VERA","3NVD.UK","LU2250418816.HKD","LU1674673691.USD","2NVD.UK","NVD","LU0048584097.USD","SNVD.UK","NVD3.UK","NVDA","NVDY","LU2168563687.JPY","NVDS.UK","LU0965509010.AUD","IE0034235303.USD","IE0034235295.USD","LU1914381329.SGD","LU1720051108.HKD","NVDU","LU1629891620.HKD","LU0353189680.USD","LU1861127337.USD"],"gpt_icon":0},{"id":"2534729082","title":"Vera Therapeutics, Inc.盘中异动 早盘大幅拉升5.90%报22.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534729082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534729082?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:32","pubTimestamp":1747056757,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时32分,Vera Therapeutics, Inc.股票出现异动,股价大幅拉升5.90%。截至发稿,该股报22.99美元/股,成交量5915股,换手率0.01%,振幅0.02%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.涨幅较大,Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为289.16%、60.91%、58.53%,振幅较大的相关个股有Athira Pharma, Inc.、Engene Holdings Inc.、Imunon, Inc.,振幅分别为12.86%、11.32%、9.99%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221323797574464&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221323797574464&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4588","BK4007","BK4585","VERA","LENZ","BK4139"],"gpt_icon":0},{"id":"1184174664","title":"异动解读 | Vera Therapeutics盘中大涨5.17%,分析师维持买入评级目标价75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184174664","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184174664?lang=zh_cn&edition=full","pubTime":"2025-05-09 22:07","pubTimestamp":1746799641,"startTime":"0","endTime":"0","summary":"生物科技公司Vera Therapeutics今日盘中股价大涨5.17%,引发市场关注。截至发稿,该股报23.17美元/股。此次股价上涨主要受益于分析师的积极评级。知名投资银行HC Wainwright & Co.重申了对Vera Therapeutics的\"买入\"评级,并给出了75美元的目标价。值得注意的是,Vera Therapeutics是一家专注于开发严重免疫疾病治疗方案的临床阶段生物科技公司。其主要候选产品atacicept是一种用于治疗某些自身免疫性疾病的融合蛋白。投资者应密切关注公司后续的临床试验进展和产品开发情况。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Vera Therapeutics盘中大涨5.17%,分析师维持买入评级目标价75美元","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VERA"],"gpt_icon":0},{"id":"2533430136","title":"Vera Therapeutics, Inc.盘中异动 早盘急速下跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533430136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533430136?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:49","pubTimestamp":1746712199,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时49分,Vera Therapeutics, Inc.股票出现波动,股价急速跳水5.39%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为3.03%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。消息层面,截至21时50分,《HC Wainwright & Co.:假定Vera Therapeutics买入评级, 目标价75.00美元。》资讯为影响Vera Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821500097534d8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050821500097534d8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","LENZ","BK4585","BK4588","BK4139","VERA"],"gpt_icon":0},{"id":"2533930989","title":"坎托菲茨杰拉德公司:维持Vera Therapeutics评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2533930989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533930989?lang=zh_cn&edition=full","pubTime":"2025-05-07 22:41","pubTimestamp":1746628875,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司:维持Vera Therapeutics(VERA.US)评级,由增持调整至增持评级,目标价由107.00美元调整至100.00美元。Vera Therapeutics(VERA.US)公司简介:Vera Therapeutics Inc是一家临床阶段的生物技术公司。该公司专注于为患有严重免疫疾病的患者开发变革性疗法并将其商业化。该公司的候选产品是atacicept,是一种融合蛋白,每周皮下注射一次,可阻断B淋巴细胞刺激剂和增殖诱导配体,它们会刺激B细胞和浆细胞产生导致某些自身免疫性疾病的自身抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224520a4757e79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERA","LENZ"],"gpt_icon":0},{"id":"2533899654","title":"Vera Therapeutics, Inc.盘中异动 大幅跳水5.05%报24.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533899654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533899654?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:52","pubTimestamp":1746546778,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时52分,Vera Therapeutics, Inc.股票出现异动,股价大幅下跌5.05%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为4.99%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。消息层面,截至23时52分,《HC Wainwright & Co.:假定Vera Therapeutics买入评级, 目标价75.00美元。》资讯为影响Vera Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050623525894ee2901&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050623525894ee2901&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","VERA","BK4007","BK4539","LENZ","BK4585"],"gpt_icon":0},{"id":"2533530372","title":"HC Wainwright & Co.:假定Vera Therapeutics(VERA.US)买入评级, 目标价75.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533530372","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533530372?lang=zh_cn&edition=full","pubTime":"2025-05-06 00:23","pubTimestamp":1746462188,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:假定Vera Therapeutics(VERA.US)买入评级, 目标价75.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/06002350140147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","VERA"],"gpt_icon":0},{"id":"2532820241","title":"Vera Therapeutics, Inc.盘中异动 股价大涨5.03%报24.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532820241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532820241?lang=zh_cn&edition=full","pubTime":"2025-05-03 01:39","pubTimestamp":1746207575,"startTime":"0","endTime":"0","summary":"北京时间2025年05月03日01时39分,Vera Therapeutics, Inc.股票出现波动,股价大幅拉升5.03%。截至发稿,该股报24.95美元/股,成交量50.5626万股,换手率0.79%,振幅4.53%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.87%。其相关个股中,Polyrizon Ltd.、Impact Biomedical, Inc.、Biovie Inc.涨幅较大,Impact Biomedical, Inc.、Pmgc Holdings Inc.、Polyrizon Ltd.较为活跃,换手率分别为1360.42%、810.81%、725.09%,振幅较大的相关个股有Polyrizon Ltd.、Impact Biomedical, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为267.88%、119.72%、71.36%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503013935974d8513&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503013935974d8513&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERA","BK4588","BK4007","LENZ","BK4585","BK4539","BK4139"],"gpt_icon":0},{"id":"2526619316","title":"Vera Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%报22.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526619316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526619316?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:43","pubTimestamp":1744393386,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时43分,Vera Therapeutics, Inc.股票出现异动,股价大幅拉升5.04%。截至发稿,该股报22.91美元/股,成交量36.6769万股,换手率0.58%,振幅8.94%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.90%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大,Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为2117.08%、1654.53%、399.09%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.,振幅分别为193.75%、156.27%、77.44%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014307a4566853&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014307a4566853&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4588","VERA","BK4539","BK4585","LENZ"],"gpt_icon":0},{"id":"2518207880","title":"Vera Therapeutics, Inc.盘中异动 下午盘股价大跌5.10%报27.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518207880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518207880?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:02","pubTimestamp":1741633362,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时02分,Vera Therapeutics, Inc.股票出现异动,股价大幅下跌5.10%。截至发稿,该股报27.35美元/股,成交量34.9152万股,换手率0.55%,振幅5.69%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。其相关个股中,Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大,Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃,换手率分别为6185.95%、3855.31%、1016.34%,振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc,振幅分别为90.44%、88.14%、59.34%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103024298a2dc61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103024298a2dc61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","LENZ","BK4139","BK4539","VERA"],"gpt_icon":0},{"id":"2517592133","title":"Vera Therapeutics, Inc.盘中异动 股价大涨5.28%报30.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517592133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517592133?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:53","pubTimestamp":1741208002,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时53分,Vera Therapeutics, Inc.股票出现波动,股价快速拉升5.28%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.87%。其相关个股中,Nkgen Biotech Inc C/Wts 31/05/2028、Chimerix, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Silexion Therapeutics Corp、Tc Biopharm Plc、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为990.11%、322.79%、321.36%,振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为497.01%、82.59%、54.27%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045323abea1c37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045323abea1c37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LENZ","VERA","BK4588","BK4539","BK4139"],"gpt_icon":0},{"id":"2516663454","title":"Vera Therapeutics, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663454?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:44","pubTimestamp":1741034655,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时44分,Vera Therapeutics, Inc.股票出现波动,股价大幅跳水5.08%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.24%。其相关个股中,Abpro Holdings Inc C/Wts 12/11/2029 、Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大,Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃,换手率分别为4654.37%、216.36%、188.06%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.,振幅分别为206.20%、119.50%、70.53%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044416a25da762&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044416a25da762&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","LENZ","BK4139","BK4539","VERA"],"gpt_icon":0},{"id":"2514382851","title":"Vera Therapeutics, Inc.盘中异动 早盘股价大涨5.08%报29.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514382851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514382851?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:02","pubTimestamp":1740672133,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时02分,Vera Therapeutics, Inc.股票出现异动,股价急速拉升5.08%。截至发稿,该股报29.18美元/股,成交量9.7414万股,换手率0.15%,振幅3.29%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。其相关个股中,Quoin Pharmaceuticals Ltd、Alpha Tau Medical Ltd C/Wts 、Pepgen Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为1480.34%、246.33%、109.54%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Quoin Pharmaceuticals Ltd、Pds Biotechnology Corporation,振幅分别为86.14%、47.79%、45.45%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000213abdf8540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000213abdf8540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4585","BK4139","BK4588","VERA","LENZ"],"gpt_icon":0},{"id":"2514856036","title":"Vera Therapeutics, Inc.盘中异动 快速拉升5.06%报28.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856036?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580337,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分,Vera Therapeutics, Inc.股票出现波动,股价大幅拉升5.06%。截至发稿,该股报28.47美元/股,成交量1.2618万股,换手率0.02%,振幅2.10%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大,Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为2818.09%、118.03%、90.31%,振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.,振幅分别为35.59%、16.86%、14.35%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223217a254f69f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223217a254f69f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4588","BK4539","BK4585","BK4139","VERA"],"gpt_icon":0},{"id":"1153119985","title":"Vera Therapeutics 2024 财年 GAAP 每股收益 $(2.75) 超过 $(2.83) 预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1153119985","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153119985?lang=zh_cn&edition=full","pubTime":"2025-02-26 21:38","pubTimestamp":1740577116,"startTime":"0","endTime":"0","summary":"Vera Therapeutics报告季度每股亏损为 $,这比分析师一致预估的 $ 高出2.83%。与去年同期每股亏损 $ 相比,这一数字下降了22.22%。以上内容来自Benzinga Earnings专栏,原文如下:Vera $Therapeutics$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 2.83 percent. This is a 22.22 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","VERA"],"gpt_icon":0},{"id":"2512166077","title":"Vera Therapeutics, Inc.盘中异动 急速拉升6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166077?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889129,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分,Vera Therapeutics, Inc.股票出现异动,股价大幅拉升6.34%。截至发稿,该股报29.20美元/股,成交量3.05万股,换手率0.05%,振幅3.53%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.11%。其相关个股中,Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大,Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为276.09%、91.01%、60.62%,振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Allakos Inc.、Virpax Pharmaceuticals, Inc.,振幅分别为8.57%、8.35%、6.13%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232099889fca3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232099889fca3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERA","BK4539","BK4585","LENZ","BK4139","BK4588"],"gpt_icon":0},{"id":"2511993146","title":"Vera Therapeutics, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511993146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511993146?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:50","pubTimestamp":1739544622,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时50分,Vera Therapeutics, Inc.股票出现波动,股价大幅下跌5.03%。截至发稿,该股报32.46美元/股,成交量5.2783万股,换手率0.08%,振幅5.56%。Vera Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.45%。其相关个股中,Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大,Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为1914.86%、497.45%、427.85%,振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.,振幅分别为66.93%、32.93%、32.49%。Vera Therapeutics, Inc.公司简介:Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422502398858e62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422502398858e62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","VERA","BK4588","BK4139","BK4585","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.veratx.com","stockEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0202},{"period":"3month","weight":0.0923},{"period":"6month","weight":-0.2923},{"period":"1year","weight":-0.3687},{"period":"ytd","weight":-0.4514}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.0421},{"period":"3month","weight":0.1835},{"period":"6month","weight":0.0516},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.0615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vera Therapeutics, Inc.最初于2016年5月在特拉华州注册成立,名称为CDF Therapeutics,Inc.,并于2020年4月更名为Vera Therapeutics, Inc.。该公司是一家处于临床后期阶段的生物技术公司,专注于为患有严重免疫疾病的患者开发和商业化转化疗法。该公司的主要候选产品atacicept是一种自我给药的融合蛋白,可阻断B淋巴细胞刺激物和增殖诱导配体,具有治疗IgA肾病的同类最佳潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":0.108417},{"month":2,"riseRate":0.5,"avgChangeRate":0.034073},{"month":3,"riseRate":0.5,"avgChangeRate":-0.056274},{"month":4,"riseRate":0,"avgChangeRate":-0.100599},{"month":5,"riseRate":0.25,"avgChangeRate":-0.061241},{"month":6,"riseRate":0.4,"avgChangeRate":0.164504},{"month":7,"riseRate":0.8,"avgChangeRate":0.158088},{"month":8,"riseRate":0.5,"avgChangeRate":0.013669},{"month":9,"riseRate":0.5,"avgChangeRate":0.025362},{"month":10,"riseRate":0.25,"avgChangeRate":-0.084104},{"month":11,"riseRate":0.75,"avgChangeRate":0.31962},{"month":12,"riseRate":0.5,"avgChangeRate":-0.027461}],"exchange":"NASDAQ","name":"Vera Therapeutics, Inc.","nameEN":"Vera Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vera Therapeutics, Inc.(VERA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vera Therapeutics, Inc.(VERA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vera Therapeutics, Inc.,VERA,Vera Therapeutics, Inc.股票,Vera Therapeutics, Inc.股票老虎,Vera Therapeutics, Inc.股票老虎国际,Vera Therapeutics, Inc.行情,Vera Therapeutics, Inc.股票行情,Vera Therapeutics, Inc.股价,Vera Therapeutics, Inc.股市,Vera Therapeutics, Inc.股票价格,Vera Therapeutics, Inc.股票交易,Vera Therapeutics, Inc.股票购买,Vera Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vera Therapeutics, Inc.(VERA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vera Therapeutics, Inc.(VERA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}